47,600 Shares in Avanos Medical, Inc. $AVNS Bought by Harvest Management LLC

Harvest Management LLC bought a new stake in Avanos Medical, Inc. (NYSE:AVNS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 47,600 shares of the company’s stock, valued at approximately $1,184,000. Avanos Medical makes up about 0.5% of Harvest Management LLC’s investment portfolio, making the stock its 24th largest holding.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio bought a new stake in Avanos Medical during the 2nd quarter worth about $48,000. EverSource Wealth Advisors LLC boosted its stake in shares of Avanos Medical by 132.6% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,496 shares of the company’s stock worth $28,000 after buying an additional 1,423 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Avanos Medical by 969.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 2,545 shares of the company’s stock valued at $31,000 after acquiring an additional 2,307 shares in the last quarter. Longfellow Investment Management Co. LLC bought a new position in shares of Avanos Medical in the 2nd quarter valued at about $75,000. Finally, Wexford Capital LP acquired a new stake in shares of Avanos Medical in the third quarter valued at about $70,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on AVNS. Weiss Ratings reiterated a “sell (d-)” rating on shares of Avanos Medical in a report on Monday, July 20th. Zacks Research upgraded Avanos Medical from a “strong sell” rating to a “hold” rating in a research note on Friday, June 5th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Avanos Medical has an average rating of “Reduce”.

Avanos Medical Stock Performance

Shares of AVNS stock opened at $24.99 on Friday. The stock has a market cap of $1.17 billion, a P/E ratio of -15.52 and a beta of 1.57. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.48 and a quick ratio of 1.40. The company has a fifty day moving average price of $24.96 and a two-hundred day moving average price of $21.40. Avanos Medical, Inc. has a one year low of $9.30 and a one year high of $25.49.

About Avanos Medical

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.